{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:57:39Z","timestamp":1776329859925,"version":"3.50.1"},"reference-count":17,"publisher":"Baskent University","issue":"Suppl 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.6002\/ect.mesot2023.p8","type":"journal-issue","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T08:35:07Z","timestamp":1708072507000},"source":"Crossref","is-referenced-by-count":1,"title":[],"prefix":"10.6002","volume":"22","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Busuttil RW, Lake JR. Role of tacrolimus in the evolution of liver transplantation. Transplantation. 2004;77(9 Suppl):S44-51. doi:10.1097\/01.tp.0000126927.49589.3f","DOI":"10.1097\/01.TP.0000126927.49589.3F"},{"key":"ref1","unstructured":"2. Robles-Piedras AL, Gonzalez-Lopez EH. Tacrolimus levels in adult patients with renal transplant. Proc West Pharmacol Soc. 2009;52:33-34."},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Shi WL, Tang HL, Zhai SD. Effects of the CYP3A4*1B genetic polymorphism on the pharmacokinetics of tacrolimus in adult renal transplant recipients: a meta-analysis. PLoS One. 2015;10(6):e0127995. doi:10.1371\/journal.pone.0127995","DOI":"10.1371\/journal.pone.0127995"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Margreiter R; European Tacrolimus vs Ciclosporin Microemulsion Renal Transplantation Study Group. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study. Lancet. 2002;359(9308):741-746. doi:10.1016\/S0140-6736(02)07875-3","DOI":"10.1016\/S0140-6736(02)07875-3"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Chen JW, Pehlivan M, Gunson BK, Buckeis JA, McMaster P, Mayer D. Ten-year results of a randomized prospective study of FK506 versus cyclosporine in management of primary orthotopic liver transplantation. Transplant Proc. 2002;34(5):1507-1510. doi:10.1016\/s0041-1345(02)02950-0","DOI":"10.1016\/S0041-1345(02)02950-0"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Curtin JC, Cantino D, Biasi F, et al. Reperfusion damage to the bile canalicoli in transplanted human liver. Hepatology. 1996;24(5):1053-1057. doi:10.1002\/hep.510240512","DOI":"10.1002\/hep.510240512"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Wiesner RH, Ludwig J, Von Hoek B, Krom RA. Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. Hepatology. 1991;14(4 Pt 1):721-729. doi:10.1016\/0270-9139(91)90064-3","DOI":"10.1016\/0270-9139(91)90064-3"},{"key":"ref7","unstructured":"8. Colina F, Lopez-Carreira M, Moreno E, et al. A clinopathologic review of 8 liver graft primary nonfunctions. Hepatogastroenterology. 1995;42(3):212-221."},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Abbasoglu O, Levy MF, Vodapally MS, et al. Hepatic artery stenosis after liver transplantation; incidence, presentation, treatment and long-term outcome. Transplantation. 1997;63(2):250-255. doi:10.1097\/00007890-199701270-00013","DOI":"10.1097\/00007890-199701270-00013"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Tischer S, Fontana RJ. Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting. J Hepatol. 2014;60(4):872-884. doi:10.1016\/j.jhep.2013.11.013","DOI":"10.1016\/j.jhep.2013.11.013"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Provenzani A, Notarbartolo M, Labbozzetta M, et al. Unusual high dose of tacrolimus in liver transplant patient, a case report. Int J Clin Pharm. 2012;34(2):269-271. doi:10.1007\/s11096-012-9622-6","DOI":"10.1007\/s11096-012-9622-6"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Yu YY, Ji J, Zhou GW, et al. Liver biopsy in evaluation of complications following liver transplantation. World J Gastroenterol. 2004;10(11):1678-1681. doi:10.3748\/wjg.v10.i11.1678","DOI":"10.3748\/wjg.v10.i11.1678"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Varghese J, Reddy MS, Venugopal K, et al. Tacrolimus-related adverse effects in liver transplant recipients: its association with trough concentrations. Indian J Gastroenterol. 2014;33(3):219-225. doi:10.1007\/s12664-014-0456-0","DOI":"10.1007\/s12664-014-0456-0"},{"key":"ref13","unstructured":"14. Soresi M, Sparacino V, Pisciotta G, et al. Effects of cyclosporin A on various indices of cholestasis in kidney transplant recipients. Minerva Urol Nefrol. 1995;47(2):65-69."},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Berenguer M, Aguilera V, Rubin A, Ortiz C, Jimenez M, Prieto M. Comparison of two non-contemperaneous HCV-liver transplant cohorts: strategies to improve the efficacy of antiviral therapy. J Hepatol. 2012;56(6):1310-1316. doi:10.1016\/j.jhep.2011.12.031","DOI":"10.1016\/j.jhep.2011.12.031"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Jantz AS, Patel SJ, Suki WN, Knight RJ, Bhimaraj A, Gaber AO. Treatment of acute tacrolimus toxicity with phenytoin in solid organ transplant recipients. Case Rep Transplant. 2013;2013:375263. doi:10.1155\/2013\/375263","DOI":"10.1155\/2013\/375263"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Yadav DK, Gera DN, Gumber MR, Kute VB, Patel MP, Vanikar AV, Trivedi HL. Tacrolimus-induced severe cholestasis complicating renal transplantation. Ren Fail. 2013;35(5):735-737. doi:10.3109\/0886022X.2013.780621","DOI":"10.3109\/0886022X.2013.780621"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T03:34:33Z","timestamp":1708313673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/supplement\/2024\/22\/1\/1\/338\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":17,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2024,1]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.mesot2023.p8","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}